Efficacy and safety of fibroblast growth factor 21 analogs in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: A systematic review and network meta-analysis.

求助中 20 由飞飞发布于 2026/1/28 17:35:42

DOI:10.1016/j.jpet.2025.103786
作者：Marwa Muhammed Abdeljawad,?Mohammed Tarek Hasan,?Areeba Fareed,?Khaled Abouelmagd,?Sara Adel Abdelkader Saed,?Shujaat Ali,?Menna Keshk,?Misha Khan,?Nouran A Taha,?Amira Mohamed Taha
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Metabolic dysfunction-associated steatotic liver disease has emerged as a global public health concern. Fibroblast growth factor 21, a liver hormone, is gaining interest because of its abili

应助信息

等您来应助

上传文件

3小时前

Book学术机器人

2026/1/28 17:35:42 未找到该文献，机器人已退出，请等待人工下载

2026/1/28 17:35:42 Book学术AI机器人收到请求，开始寻找文献

2026/1/28 17:35:42 已向机器人发送请求

3小时前

飞飞发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Elsevier3D connectivity calculation method for low-dip fractures in high-steep rock slopes